StreetInsider.com News Articles

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

INCHEON, South Korea, July 2, 2026 /PRNewswire/ -- SK bioscience announced that it will lead the Research Optimization & Trial Outcome Recommender (ROTOR) project, an AI-powered evidence synthesis and clinical development decision-support platform initiative funded by the Gates Foundation,

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

Thu, 02 Jul 2026 08:00:00 -0400

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.
SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making.
The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in LMICs.

SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development

Tue, 09 Jun 2026 08:00:00 -0400

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention
SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity
"We are committed to improving public health through continuous innovation and global partnership."

INCHEON, South Korea, June 9, 2026 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that, after entering into a license agreement with the U.S. Centers for Disease Control and Prevention (CDC), it has